-+ 0.00%
-+ 0.00%
-+ 0.00%

MONTE ROSA THERAPEUTICS SHARES UP 50.9% PREMARKET AFTER $5.7 BILLION DRUG DEVELOPMENT DEAL WITH NOVARTIS

Reuters·09/15/2025 11:15:54

Please log in to view news